Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 08:33 am Sale |
2023-12-31 | 13G | Albireo Pharma, Inc. ALBO |
Deep Track Capital, LP | 0 0.000% |
-1,704,000 (Position Closed) |
Filing History |
| 2023-04-10 11:22 am Sale |
2023-03-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
0 0.000% |
-1,956,488 (Position Closed) |
Filing History |
| 2023-03-08 2:01 pm Sale |
2023-02-28 | 13G | Albireo Pharma, Inc. ALBO |
BLACKROCK INC BLK |
506,425 2.400% |
-838,472 (-62.34%) |
Filing History |
| 2023-03-02 4:26 pm Purchase |
2023-02-21 | 13G | Albireo Pharma, Inc. ALBO |
ICS OPPORTUNITIES LTD. | 999,363 4.800% |
999,363 (New Position) |
Filing History |
| 2023-02-27 4:05 pm Purchase |
2023-02-16 | 13G | Albireo Pharma, Inc. ALBO |
Beryl Capital Management LLC | 1,483,599 7.100% |
1,483,599 (New Position) |
Filing History |
| 2023-02-24 5:24 pm Purchase |
2023-02-17 | 13G | Albireo Pharma, Inc. ALBO |
CARLSON CAPITAL L P | 1,075,000 5.200% |
1,075,000 (New Position) |
Filing History |
| 2023-02-14 4:00 pm Sale |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
TANG CAPITAL PARTNERS LP | 411,968 2.000% |
-687,548 (-62.53%) |
Filing History |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
PERCEPTIVE ADVISORS LLC | 1,757,160 8.500% |
-602,979 (-25.55%) |
Filing History |
| 2023-02-14 08:23 am Purchase |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
Deep Track Capital, LP | 1,704,000 8.230% |
579,579 (+51.54%) |
Filing History |
| 2023-02-01 09:56 am Sale |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
STATE STREET CORP STT |
348,114 1.680% |
-644,718 (-64.94%) |
Filing History |
| 2023-02-01 09:07 am Sale |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
1,956,488 9.450% |
-402,136 (-17.05%) |
Filing History |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
BLACKROCK INC BLK |
1,344,897 6.500% |
176,114 (+15.07%) |
Filing History |
| 2023-01-23 12:49 pm Purchase |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
Chicago Capital LLC | 1,362,484 6.600% |
390,599 (+40.19%) |
Filing History |
| 2022-10-03 4:37 pm Purchase |
2022-09-23 | 13G | Albireo Pharma, Inc. ALBO |
Deep Track Capital, LP | 1,124,421 5.460% |
1,124,421 (New Position) |
Filing History |
| 2022-09-26 4:00 pm Purchase |
2022-09-15 | 13G | Albireo Pharma, Inc. ALBO |
TANG CAPITAL PARTNERS LP | 1,099,516 5.600% |
1,099,516 (New Position) |
Filing History |
| 2022-03-07 08:56 am Purchase |
2022-03-01 | 13G | Albireo Pharma, Inc. ALBO |
Chicago Capital LLC | 971,885 5.100% |
971,885 (New Position) |
Filing History |
| 2022-02-14 4:10 pm Unchanged |
2021-12-31 | 13G | Albireo Pharma, Inc. ALBO |
PERCEPTIVE ADVISORS LLC | 2,360,139 12.200% |
0 (Unchanged) |
Filing History |
| 2022-02-14 1:38 pm Sale |
2021-12-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
2,358,624 12.230% |
-88,376 (-3.61%) |
Filing History |
| 2022-02-09 4:49 pm Purchase |
2021-12-31 | 13G | Albireo Pharma, Inc. ALBO |
STATE STREET CORP STT |
992,832 5.150% |
992,832 (New Position) |
Filing History |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Albireo Pharma, Inc. ALBO |
BLACKROCK INC BLK |
1,168,783 6.100% |
-73,997 (-5.95%) |
Filing History |